Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Phase 1 Not yet recruiting 20 enrolled Medical University of South Carolina American Society for Metabolic and Bariatric Surgery · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.

Timeline

Start: 2026-09-01
Primary completion: 2027-12-31
Completion: 2027-12-31

Publications

Background Chow A, Neville A, Kolozsvari N. Smoking in bariatric surgery: a systematic review. Surg Endosc. 2021 Jun;35(6):3047-3066. doi: 10.1007/s00464-020-07669-3. Epub 2020 Jun 10.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupropion	Small molecule	150 mg	—
Subject	Naltrexone	Small molecule	50 mg	—

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Summary

Timeline

Publications

Drugs

Indications